Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women (Q42227413)

19 October 2017

Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women. (English)

1 reference

19 October 2017

1 reference

1 reference

12

Trudy V Murphy

1 reference

19 October 2017

Stephen C Ko

1

1 reference

19 October 2017

Sarah F Schillie

2

1 reference

19 October 2017

Tanja Walker

3

1 reference

19 October 2017

Steven L Veselsky

4

1 reference

19 October 2017

Noele P Nelson

5

1 reference

19 October 2017

Julie Lazaroff

6

1 reference

19 October 2017

Susan Crowley

7

1 reference

19 October 2017

Cristina Dusek

8

1 reference

19 October 2017

Khalilah Loggins

9

1 reference

19 October 2017

Kenneth Onye

10

1 reference

19 October 2017

Nancy Fenlon

11

1 reference

19 October 2017

language of work or name

English

0 references

publication date

22 February 2014

1 reference

19 October 2017

1 reference

19 October 2017

32

1 reference

19 October 2017

18

1 reference

19 October 2017

2127-2133

1 reference

The national Perinatal Hepatitis B Prevention Program, 1994-2008.

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Perinatal transmission of hepatitis B virus in high-incidence countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

The e antigen and vertical transmission of hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Hepatitis B: Evolving Epidemiology and Implications for Control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

The influence of age on the development of the hepatitis B carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Hepatitis B vaccine -- do we need boosters?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Natural history of chronic hepatitis B REVEALed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Response of preterm infants to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Long-term follow-up of hepatitis B vaccine in infants of carrier mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Hepatitis B vaccination in high-risk infants: 10-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Prevention of perinatal hepatitis B virus transmission in the Netherlands, 2003-2007: children of Chinese mothers are at increased risk of breakthrough infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Yeast-derived hepatitis B vaccine in dental students. A three-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Immunogenicity of 20 micrograms of recombinant DNA hepatitis B vaccine in healthy neonates: a comparison of three different vaccination schemes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

Hepatitis B vaccination in preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.099

10.1016/J.VACCINE.2014.01.099

7 January 2021

Identifiers

DOI

1 reference

release_m2lgsvhc4navvlix2dkdwz6ypu

19 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/m2lgsvhc4navvlix2dkdwz6ypu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference